bevaya/FinQA huggingface dataset:
part i item 1 entergy corporation , domestic utility companies , and system energy employment litigation ( entergy corporation , entergy arkansas , entergy gulf states , entergy louisiana , entergy mississippi , entergy new orleans , and system energy ) entergy corporation and the domestic utility companies are defendants in numerous lawsuits that have been filed by former employees alleging that they were wrongfully terminated and/or discriminated against on the basis of age , race , sex , and/or other protected characteristics . entergy corporation and the domestic utility companies are vigorously defending these suits and deny any liability to the plaintiffs . however , no assurance can be given as to the outcome of these cases , and at this time management cannot estimate the total amount of damages sought . included in the employment litigation are two cases filed in state court in claiborne county , mississippi in december 2002 . the two cases were filed by former employees of entergy operations who were based at grand gulf . entergy operations and entergy employees are named as defendants . the cases make employment-related claims , and seek in total $ 53 million in alleged actual damages and $ 168 million in punitive damages . entergy subsequently removed both proceedings to the federal district in jackson , mississippi . entergy cannot predict the ultimate outcome of this proceeding . research spending entergy is a member of the electric power research institute ( epri ) . epri conducts a broad range of research in major technical fields related to the electric utility industry . entergy participates in various epri projects based on entergy's needs and available resources . the domestic utility companies contributed $ 1.6 million in 2004 , $ 1.5 million in 2003 , and $ 2.1 million in 2002 to epri . the non-utility nuclear business contributed $ 3.2 million in 2004 and $ 3 million in both 2003 and 2002 to epri . employees employees are an integral part of entergy's commitment to serving its customers . as of december 31 , 2004 , entergy employed 14425 people . u.s . utility: .

Table: entergy arkansas 1494 entergy gulf states 1641 entergy louisiana 943 entergy mississippi 793 entergy new orleans 403 system energy - entergy operations 2735 entergy services 2704 entergy nuclear operations 3245 other subsidiaries 277 total full-time 14235 part-time 190 total entergy 14425

approximately 4900 employees are represented by the international brotherhood of electrical workers union , the utility workers union of america , and the international brotherhood of teamsters union. .

Question: what percent of total full-time employees are in entergy nuclear operations?
Answer: 23%
Calculation: divide(3245, 14235)
devon energy corporation and subsidiaries notes to consolidated financial statements 2013 ( continued ) other debentures and notes following are descriptions of the various other debentures and notes outstanding at december 31 , 2014 and 2013 , as listed in the table presented at the beginning of this note . geosouthern debt in december 2013 , in conjunction with the planned geosouthern acquisition , devon issued $ 2.25 billion aggregate principal amount of fixed and floating rate senior notes resulting in cash proceeds of approximately $ 2.2 billion , net of discounts and issuance costs . the floating rate senior notes due in 2015 bear interest at a rate equal to three-month libor plus 0.45 percent , which rate will be reset quarterly . the floating rate senior notes due in 2016 bears interest at a rate equal to three-month libor plus 0.54 percent , which rate will be reset quarterly . the schedule below summarizes the key terms of these notes ( in millions ) . .

Table: floating rate due december 15 2015 $ 500 floating rate due december 15 2016 350 1.20% ( 1.20 % ) due december 15 2016 ( 1 ) 650 2.25% ( 2.25 % ) due december 15 2018 750 discount and issuance costs -2 ( 2 ) net proceeds $ 2248

( 1 ) the 1.20% ( 1.20 % ) $ 650 million note due december 15 , 2016 was redeemed on november 13 , 2014 . the senior notes were classified as short-term debt on devon 2019s consolidated balance sheet as of december 31 , 2013 due to certain redemption features in the event that the geosouthern acquisition was not completed on or prior to june 30 , 2014 . on february 28 , 2014 , the geosouthern acquisition closed and thus the senior notes were subsequently classified as long-term debt . additionally , during december 2013 , devon entered into a term loan agreement with a group of major financial institutions pursuant to which devon could draw up to $ 2.0 billion to finance , in part , the geosouthern acquisition and to pay transaction costs . in february 2014 , devon drew the $ 2.0 billion of term loans for the geosouthern transaction , and the amount was subsequently repaid on june 30 , 2014 with the canadian divestiture proceeds that were repatriated to the u.s . in june 2014 , at which point the term loan was terminated. .

Question: debt in december 2013 , what was the percent of the net of discounts and issuance costs associated with the issuance fixed and floating rate senior notes in conjunction with the planned geosouthern acquisition
Answer: 2.3%
Calculation: divide(subtract(2.25, 2.2), 2.2)
the company 2019s stock performance the following graph compares cumulative total return of the company 2019s common stock with the cumulative total return of ( i ) the nasdaq stock market-united states , and ( ii ) the nasdaq biotechnology index . the graph assumes ( a ) $ 100 was invested on july 31 , 2001 in each of the company 2019s common stock , the stocks comprising the nasdaq stock market-united states and the stocks comprising the nasdaq biotechnology index , and ( b ) the reinvestment of dividends . comparison of 65 month cumulative total return* among alexion pharmaceuticals , inc. , the nasdaq composite index and the nasdaq biotechnology index alexion pharmaceuticals , inc . nasdaq composite nasdaq biotechnology .

Table: 7/02 7/03 7/04 7/05 12/05 12/06 12/07 alexion pharmaceuticals inc . 100.00 108.38 102.64 167.89 130.56 260.41 483.75 nasdaq composite 100.00 128.98 142.51 164.85 168.24 187.43 204.78 nasdaq biotechnology 100.00 149.29 146.51 176.75 186.10 183.89 187.04

.

Question: what is the percent change in the investment into alexion pharmaceuticals between 7/02 and 7/03?
Answer: 8.4%
Calculation: divide(subtract(108.38, 100), 100)
stock total return performance the following graph compares our total return to stockholders with the returns of the standard & poor 2019s composite 500 index ( 201cs&p 500 201d ) and the dow jones us select health care providers index ( 201cpeer group 201d ) for the five years ended december 31 , 2018 . the graph assumes an investment of $ 100 in each of our common stock , the s&p 500 , and the peer group on december 31 , 2013 , and that dividends were reinvested when paid. .

Table: 12/31/2013 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 hum $ 100 $ 140 $ 176 $ 202 $ 247 $ 287 s&p 500 $ 100 $ 114 $ 115 $ 129 $ 157 $ 150 peer group $ 100 $ 128 $ 135 $ 137 $ 173 $ 191

the stock price performance included in this graph is not necessarily indicative of future stock price performance. .

Question: what is the highest return for the first year of the investment?
Answer: 40%
Calculation: subtract(140, 100)
Explanation: it is the maximum value for the first year ( 2014 ) , then turned into a percentage to represent the return .
marathon oil corporation notes to consolidated financial statements stock-based performance unit awards 2013 during 2018 , 2017 and 2016 we granted 754140 , 563631 and 1205517 stock- based performance unit awards to officers . at december 31 , 2018 , there were 1196176 units outstanding . total stock-based performance unit awards expense was $ 13 million in 2018 , $ 8 million in 2017 and $ 6 million in 2016 . the key assumptions used in the monte carlo simulation to determine the fair value of stock-based performance units granted in 2018 , 2017 and 2016 were: .

Table: 2018 2017 2016 valuation date stock price $ 14.17 $ 14.17 $ 14.17 expected annual dividend yield 1.4% ( 1.4 % ) 1.4% ( 1.4 % ) 1.4% ( 1.4 % ) expected volatility 39% ( 39 % ) 43% ( 43 % ) 52% ( 52 % ) risk-free interest rate 2.5% ( 2.5 % ) 2.6% ( 2.6 % ) 2.4% ( 2.4 % ) fair value of stock-based performance units outstanding $ 19.60 $ 19.45 $ 21.51

18 . defined benefit postretirement plans and defined contribution plan we have noncontributory defined benefit pension plans covering substantially all domestic employees , as well as u.k . employees who were hired before april 2010 . certain employees located in e.g. , who are u.s . or u.k . based , also participate in these plans . benefits under these plans are based on plan provisions specific to each plan . for the u.k . pension plan , the principal employer and plan trustees reached a decision to close the plan to future benefit accruals effective december 31 , 2015 . we also have defined benefit plans for other postretirement benefits covering our u.s . employees . health care benefits are provided up to age 65 through comprehensive hospital , surgical and major medical benefit provisions subject to various cost- sharing features . post-age 65 health care benefits are provided to certain u.s . employees on a defined contribution basis . life insurance benefits are provided to certain retiree beneficiaries . these other postretirement benefits are not funded in advance . employees hired after 2016 are not eligible for any postretirement health care or life insurance benefits. .

Question: what was the average expected annual dividend yield , in percent?
Answer: 1.4
Calculation: table_average(expected annual dividend yield, none)
december 18 , 2007 , we issued an additional 23182197 shares of common stock to citadel . the issuances were exempt from registration pursuant to section 4 ( 2 ) of the securities act of 1933 , and each purchaser has represented to us that it is an 201caccredited investor 201d as defined in regulation d promulgated under the securities act of 1933 , and that the common stock was being acquired for investment . we did not engage in a general solicitation or advertising with regard to the issuances of the common stock and have not offered securities to the public in connection with the issuances . see item 1 . business 2014citadel investment . performance graph the following performance graph shows the cumulative total return to a holder of the company 2019s common stock , assuming dividend reinvestment , compared with the cumulative total return , assuming dividend reinvestment , of the standard & poor 2019s ( 201cs&p 201d ) 500 and the s&p super cap diversified financials during the period from december 31 , 2002 through december 31 , 2007. .

Table: 12/02 12/03 12/04 12/05 12/06 12/07 e*trade financial corporation 100.00 260.29 307.61 429.22 461.32 73.05 s&p 500 100.00 128.68 142.69 149.70 173.34 182.87 s&p super cap diversified financials 100.00 139.29 156.28 170.89 211.13 176.62

2022 $ 100 invested on 12/31/02 in stock or index-including reinvestment of dividends . fiscal year ending december 31 . 2022 copyright a9 2008 , standard & poor 2019s , a division of the mcgraw-hill companies , inc . all rights reserved . www.researchdatagroup.com/s&p.htm .

Question: what was the percent of the growth in the total cumulative value of the common stock for e*trade financial corporation from 2004 to 2005
Answer: 39.5%
Calculation: divide(subtract(429.22, 307.61), 307.61)
Explanation: the total cumulative value of the common stock for e*trade financial corporation increased by 39.5% from 2004 to 2005
other long term debt in december 2012 , the company entered into a $ 50.0 million recourse loan collateralized by the land , buildings and tenant improvements comprising the company 2019s corporate headquarters . the loan has a seven year term and maturity date of december 2019 . the loan bears interest at one month libor plus a margin of 1.50% ( 1.50 % ) , and allows for prepayment without penalty . the loan includes covenants and events of default substantially consistent with the company 2019s credit agreement discussed above . the loan also requires prior approval of the lender for certain matters related to the property , including transfers of any interest in the property . as of december 31 , 2017 and 2016 , the outstanding balance on the loan was $ 40.0 million and $ 42.0 million , respectively . the weighted average interest rate on the loan was 2.5% ( 2.5 % ) and 2.0% ( 2.0 % ) for the years ended december 31 , 2017 and 2016 , respectively . the following are the scheduled maturities of long term debt as of december 31 , 2017 : ( in thousands ) .

Table: 2018 $ 27000 2019 63000 2020 25000 2021 86250 2022 2014 2023 and thereafter 600000 total scheduled maturities of long term debt $ 801250 current maturities of long term debt $ 27000

interest expense , net was $ 34.5 million , $ 26.4 million , and $ 14.6 million for the years ended december 31 , 2017 , 2016 and 2015 , respectively . interest expense includes the amortization of deferred financing costs , bank fees , capital and built-to-suit lease interest and interest expense under the credit and other long term debt facilities . amortization of deferred financing costs was $ 1.3 million , $ 1.2 million , and $ 0.8 million for the years ended december 31 , 2017 , 2016 and 2015 , respectively . the company monitors the financial health and stability of its lenders under the credit and other long term debt facilities , however during any period of significant instability in the credit markets lenders could be negatively impacted in their ability to perform under these facilities . 7 . commitments and contingencies obligations under operating leases the company leases warehouse space , office facilities , space for its brand and factory house stores and certain equipment under non-cancelable operating leases . the leases expire at various dates through 2033 , excluding extensions at the company 2019s option , and include provisions for rental adjustments . the table below includes executed lease agreements for brand and factory house stores that the company did not yet occupy as of december 31 , 2017 and does not include contingent rent the company may incur at its stores based on future sales above a specified minimum or payments made for maintenance , insurance and real estate taxes . the following is a schedule of future minimum lease payments for non-cancelable real property operating leases as of december 31 , 2017 as well as .

Question: what is the percentage increase in interest expense from 2016 to 2017?
Answer: 30.7%
Calculation: divide(subtract(34.5, 26.4), 26.4)
performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citi 2019s common stock , which is listed on the nyse under the ticker symbol 201cc 201d and held by 77787 common stockholders of record as of january 31 , 2017 , with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period through december 31 , 2016 . the graph and table assume that $ 100 was invested on december 31 , 2011 in citi 2019s common stock , the s&p 500 index and the s&p financial index , and that all dividends were reinvested . comparison of five-year cumulative total return for the years ended date citi s&p 500 financials .

Table: date citi s&p 500 s&p financials 31-dec-2011 100.0 100.0 100.0 31-dec-2012 150.6 116.0 128.8 31-dec-2013 198.5 153.6 174.7 31-dec-2014 206.3 174.6 201.3 31-dec-2015 197.8 177.0 198.2 31-dec-2016 229.3 198.2 243.4

.

Question: what was the difference in percentage cumulative total return between citi common stock and the s&p 500 for the five years ended december 31 , 2016?
Answer: 31.1%
Calculation: subtract(divide(subtract(229.3, const_100), const_100), divide(subtract(198.2, const_100), const_100))
edwards lifesciences corporation notes to consolidated financial statements ( continued ) 2 . summary of significant accounting policies ( continued ) interim periods therein . the new guidance can be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of the change recognized at the date of the initial application . the company is currently assessing the impact this guidance will have on its consolidated financial statements , and has not yet selected a transition method . 3 . change in accounting principle effective january 1 , 2014 , the company changed its method of accounting for certain intellectual property litigation expenses related to the defense and enforcement of its issued patents . previously , the company capitalized these legal costs if a favorable outcome in the patent defense was determined to be probable , and amortized the capitalized legal costs over the life of the related patent . as of december 31 , 2013 , the company had remaining unamortized capitalized legal costs of $ 23.7 million , which , under the previous accounting method , would have been amortized through 2021 . under the new method of accounting , these legal costs are expensed in the period they are incurred . the company has retrospectively adjusted the comparative financial statements of prior periods to apply this new method of accounting . the company believes this change in accounting principle is preferable because ( 1 ) as more competitors enter the company 2019s key product markets and the threat of complex intellectual property litigation across multiple jurisdictions increases , it will become more difficult for the company to accurately assess the probability of a favorable outcome in such litigation , and ( 2 ) it will enhance the comparability of the company 2019s financial results with those of its peer group because it is the predominant accounting practice in the company 2019s industry . the accompanying consolidated financial statements and related notes have been adjusted to reflect the impact of this change retrospectively to all prior periods presented . the cumulative effect of the change in accounting principle was a decrease in retained earnings of $ 10.5 million as of january 1 , 2012 . the following tables present the effects of the retrospective application of the change in accounting principle ( in millions ) : .

Table: consolidated balance sheet as of december 31 2013 as reported as of december 31 2013 as adjusted other intangible assets net $ 57.2 $ 33.5 deferred income taxes 70.1 79.0 total assets 2724.7 2709.9 retained earnings 2045.6 2030.8 total stockholders' equity 1559.2 1544.4 total liabilities and stockholders' equity 2724.7 2709.9

.

Question: what was the affect of the change in accounting principles on differed income taxes in millions?
Answer: 8.9
Calculation: subtract(79.0, 70.1)
operating expenses as a percentage of total revenue .

Table: 2006 2005 2004 marketing and sales 27% ( 27 % ) 28% ( 28 % ) 28% ( 28 % ) research and development 31% ( 31 % ) 29% ( 29 % ) 31% ( 31 % ) general and administrative 10% ( 10 % ) 10% ( 10 % ) 7% ( 7 % )

operating expense summary 2006 compared to 2005 overall operating expenses increased $ 122.5 million in 2006 , as compared to 2005 , primarily due to : 2022 an increase of $ 58.4 million in stock-based compensation expense due to our adoption of sfas no . 123r ; and 2022 an increase of $ 49.2 million in salary , benefits and other employee-related costs , primarily due to an increased number of employees and increases in bonus and commission costs , in part due to our acquisition of verisity ltd. , or verisity , in the second quarter of 2005 . 2005 compared to 2004 operating expenses increased $ 97.4 million in 2005 , as compared to 2004 , primarily due to : 2022 an increase of $ 63.3 million in employee salary and benefit costs , primarily due to our acquisition of verisity and increased bonus and commission costs ; 2022 an increase of $ 9.9 million in stock-based compensation expense due to grants of restricted stock and the assumption of options in our acquisitions ; 2022 an increase of $ 8.6 million in losses associated with the sale of installment contract receivables ; and 2022 an increase of $ 7.1 million in costs related to the retirement of our executive chairman and former president and chief executive officer in 2005 ; partially offset by 2022 our restructuring activities , as discussed below . marketing and sales 2006 compared to 2005 marketing and sales expenses increased $ 39.4 million in 2006 , as compared to 2005 , primarily due to : 2022 an increase of $ 14.8 million in stock-based compensation expense due to our adoption of sfas no . 123r ; 2022 an increase of $ 18.2 million in employee salary , commissions , benefits and other employee-related costs due to increased hiring of sales and technical personnel , and higher commissions earned resulting from an increase in 2006 sales performance ; and 2022 an increase of $ 7.8 million in marketing programs and customer-focused conferences due to our new marketing initiatives and increased travel to visit our customers . 2005 compared to 2004 marketing and sales expenses increased $ 33.1 million in 2005 , as compared to 2004 , primarily due to : 2022 an increase of $ 29.4 million in employee salary , commission and benefit costs due to increased hiring of sales and technical personnel and higher employee bonuses and commissions ; and 2022 an increase of $ 1.6 million in stock-based compensation expense due to grants of restricted stock and the assumption of options in our acquisitions ; partially offset by 2022 a decrease of $ 1.9 million in marketing program costs. .

Question: what was the change in marketing and sales expenses as a percentage of total revenue from 2005 to 2006?
Answer: -1%
Calculation: subtract(27%, 28%)
schlumberger limited and subsidiaries shares of common stock ( stated in millions ) issued in treasury shares outstanding .

Table: issued in treasury shares outstanding balance january 1 2009 1334 -140 ( 140 ) 1194 shares sold to optionees less shares exchanged 2013 4 4 vesting of restricted stock 2013 1 1 shares issued under employee stock purchase plan 2013 4 4 stock repurchase program 2013 -8 ( 8 ) -8 ( 8 ) balance december 31 2009 1334 -139 ( 139 ) 1195 acquisition of smith international inc . 100 76 176 shares sold to optionees less shares exchanged 2013 6 6 shares issued under employee stock purchase plan 2013 3 3 stock repurchase program 2013 -27 ( 27 ) -27 ( 27 ) issued on conversions of debentures 2013 8 8 balance december 31 2010 1434 -73 ( 73 ) 1361 shares sold to optionees less shares exchanged 2013 6 6 vesting of restricted stock 2013 1 1 shares issued under employee stock purchase plan 2013 3 3 stock repurchase program 2013 -37 ( 37 ) -37 ( 37 ) balance december 31 2011 1434 -100 ( 100 ) 1334

see the notes to consolidated financial statements .

Question: what was the net change in shares outstanding during 2011?
Answer: 0
Calculation: subtract(1434, 1434)